Wordt geladen...

SABCS 2016: systemic therapy for metastatic breast cancer

At the 2016 San Antonio Breast Cancer Symposium, several interesting phase II and phase III studies investigating systemic therapies for metastatic breast cancer were presented. The PrEGOC 0102 trial demonstrated that the combination of fulvestrant plus everolimus is safe and effective and could be...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Memo
Hoofdauteurs: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Greil, Richard
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Springer Vienna 2017
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5493725/
https://ncbi.nlm.nih.gov/pubmed/28725277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12254-017-0326-4
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!